Hikma Rx chief commercial officer says division targets complex generics, innovative products

Reuters2026/07/22 14:35

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Hikma Pharmaceuticals management flagged a strategic push to expand Hikma Rx beyond its base generics franchise.
Chief Commercial Officer Kristy Ronco pointed to complex generics, innovative products, or new business development as near-term growth avenues.
Ronco said the unit has strengthened infrastructure over the past six to seven years, with quality positioned as a core operating priority.
She described the division as prepared to respond in challenging periods, framing readiness as key to sustaining growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hikma Pharmaceuticals plc published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Hikma Rx chief commercial officer says division targets complex generics, innovative products

You may also like

Crypto prices